The streak of positive phase 3 trial results for the novel “twincretin” tirzepatide when treating patients with type 2 diabetes
Questions Remain as More ‘Twincretin’ Data in Diabetes Published
Home »
FDA OKs Extended-Release Exenatide for Children With T2D
The Food and Drug Administration has approved exenatide extended release (Bydureon/Bydureon BCise, AstraZeneca) for use in children with type 2
Diabetes Could Be Main Factor Behind Accelerated Progression of COVID-19
NEW YORK (Reuters Health) – Diabetes appears to be the primary factor for accelerated progression of COVID-19, according to a
Heartburn Drugs Improve Blood Sugar Control in Diabetes
WASHINGTON—Antacids improved blood sugar control in people with diabetes but had no effect on reducing the risk of diabetes in
Sotagliflozin Use in Diabetes Tied to Survival After Discharge
Patients with type 2 diabetes who were hospitalized for worsening heart failure and who received sotagliflozin remained alive and out
Coffee Could Be the Secret Weapon Against NAFLD
Treatment of obesity through exercise and diet is unquestionably the foundation of care for patients with nonalcoholic fatty liver disease
Goldenseal May Interfere With Metformin, Jeopardize Glucose Control
Goldenseal, a natural botanical product, may interfere with intestinal absorption of metformin, potentially compromising blood glucose control in patients with
Medicare Beneficiaries With High Out-of-Pocket Costs May Reduce Insulin Adherence
NEW YORK (Reuters Health) – Patients with diabetes who face high out-of-pocket costs under Medicare Part D may buy or